Home › Biliary Tract Cancer › Rhode Island › Providence
Biliary Tract Cancer clinical trials in Providence, RI
4 studies for Biliary Tract Cancer are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RecruitingPhase 1
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693, Providence
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
RecruitingPhase 2
- Research Site, Providence
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
RecruitingPhase 3
- Research Site, Providence
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
Biliary Tract Cancer trials in other cities
- Houston, TX19 studies
- Los Angeles, CA12 studies
- New York City, NY11 studies
- Nashville, TN11 studies
- Boston, MA11 studies
- Arlington, VA9 studies
- Baltimore, MD9 studies
- Dallas, TX8 studies
- Baldwin Park, CA7 studies
- San Antonio, TX7 studies
- Columbus, OH6 studies
- Washington, DC6 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Obesity14 studies
- Endometrial Cancer14 studies
- Non-Small Cell Lung Cancer13 studies
- Cancer (all types)12 studies
- Acute Myeloid Leukemia11 studies
- Crohn's Disease10 studies
- Ulcerative Colitis10 studies
- Overweight9 studies
- Metastatic Cancer9 studies
- Breast Cancer9 studies
- Alzheimer's Disease9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.